Who
Eran Rotem
Deputy CEO and CFO
Company insider
Files Form 4 as: Deputy CEO and CFO, CollPlant Biotechnologies; Chief Financial Officer, Nexgen Biofuels.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 9 Jan 2008
- Last trade
- 3 Sep 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Sep 2026filed 8 Sep 2026 | CLGN CollPlant BiotechnologiesMedical Devices | SEC FORM 4 Code A | —510,372 at $0.00 | filing |
| 3 Sep 2026filed 8 Sep 2026 | CLGN CollPlant BiotechnologiesMedical Devices | SEC FORM 4 Code A | —510,372 at $0.00 | filing |
| 18 Mar 2008filed 26 Mar 2008 | Nexgen Biofuelsoption or derivative | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 18 Mar 2008filed 26 Mar 2008 | Nexgen Biofuelsoption or derivative | SEC FORM 4 Code M | —62,000 at $0.00 | filing |
| 18 Mar 2008filed 26 Mar 2008 | Nexgen Biofuels | SEC FORM 4 Code M | $21K55,000 at $0.38 | filing |
| 18 Mar 2008filed 26 Mar 2008 | Nexgen Biofuels | SEC FORM 4 Code M | $53K62,000 at $0.85 | filing |
| 18 Jan 2008filed 19 Mar 2008 | Nexgen Biofuelsoption or derivative | SEC FORM 4 Code M | —55,000 at $0.00 | filing |
| 18 Jan 2008filed 19 Mar 2008 | Nexgen Biofuelsoption or derivative | SEC FORM 4 Code M | —62,000 at $0.00 | filing |
| 18 Jan 2008filed 19 Mar 2008 | Nexgen Biofuels | SEC FORM 4 Code M | $21K55,000 at $0.38 | filing |
| 18 Jan 2008filed 19 Mar 2008 | Nexgen Biofuels | SEC FORM 4 Code M | $53K62,000 at $0.85 | filing |
| 9 Jan 2008filed 11 Jan 2008 | Healthcare Technologiesoption or derivative | SEC FORM 4 Code A | —650,000 at $0.00 | filing |
| 9 Jan 2008filed 11 Jan 2008 | Healthcare Technologies | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.